WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -66.06%4.13B | -50.90%6.54B | -80.85%3.85B | -74.03%5.17B | -32.45%12.18B | -43.47%13.33B | -27.71%20.12B | 53.39%19.89B | 39.08%18.03B | 117.40%23.58B |
Transactional financial assets | 55.38%101M | 41.43%99M | 14.08%81M | -1.41%70M | -9.72%65M | 1.45%70M | -8.97%71M | -10.13%71M | -14.29%72M | -21.59%69M |
Notes receivable and accounts receivable | -11.05%1.95B | 12.13%2.75B | 19.54%2.66B | 60.34%2.64B | 168.18%2.19B | 93.82%2.45B | 79.37%2.23B | 10.08%1.65B | -16.12%817M | -32.85%1.26B |
-Notes receivable | --59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accounts receivable | -13.74%1.89B | 12.13%2.75B | 19.54%2.66B | 60.34%2.64B | 168.18%2.19B | 93.82%2.45B | 79.37%2.23B | 10.08%1.65B | -16.12%817M | -32.85%1.26B |
Other receivables (including interest and dividends) | 27.82%2.93B | 74.57%3.52B | 8.40%3.05B | 4.87%2.58B | 2.60%2.29B | 1.66%2.02B | 29.36%2.81B | -0.85%2.46B | -6.88%2.23B | -18.08%1.98B |
-Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12M | ---- |
-Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Other receivable | 27.82%2.93B | ---- | --3.05B | ---- | 3.15%2.29B | ---- | ---- | ---- | --2.22B | ---- |
Advance payment | -27.01%227M | -17.39%209M | -11.74%203M | 22.58%304M | -23.02%311M | -6.64%253M | 35.29%230M | 0.40%248M | 152.50%404M | -28.31%271M |
Inventories | 2.44%1.68B | 7.87%1.82B | 6.53%1.81B | 1.00%1.72B | -0.97%1.64B | -4.36%1.69B | -7.10%1.7B | -6.75%1.7B | -7.95%1.66B | -9.93%1.77B |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | 0.00%2M |
Non-current assets due within one year | 7.71%447M | -8.70%210M | -8.70%210M | 68.09%395M | 74.37%415M | -5.35%230M | -5.35%230M | -22.70%235M | -21.71%238M | -32.31%243M |
Other current assets | 12.99%7.58B | 27.79%7.1B | 21.35%6.72B | 2.96%6.01B | 46.08%6.71B | 2.28%5.56B | 17.76%5.54B | -32.52%5.84B | -50.22%4.59B | -36.20%5.43B |
Exceptional items of current assets | 250.00%56M | ---- | 57.14%11M | 1,400.00%15M | 1,500.00%16M | -55.56%64M | -89.06%7M | -95.00%1M | --1M | --144M |
Total current assets | -26.00%19.1B | -13.27%22.25B | -43.54%18.6B | -41.09%18.91B | -7.93%25.82B | -26.17%25.66B | -14.10%32.94B | 14.31%32.09B | 0.47%28.04B | 31.38%34.75B |
Non Current assets | ||||||||||
Other equity investment | 34.06%1.42B | 116.07%968M | 109.23%929M | 144.44%990M | 133.85%1.06B | 34.94%448M | 19.03%444M | -3.11%405M | -1.09%452M | -62.01%332M |
Investment real estate | -65.34%96M | 33.19%305M | 13.08%268M | 26.27%274M | 11.69%277M | 104.46%229M | 107.89%237M | 85.47%217M | 110.17%248M | -29.11%112M |
Long-term equity investment | 8.64%2.73B | -2.23%2.72B | -2.83%2.64B | -6.19%2.53B | 0.68%2.51B | 23.43%2.78B | 21.51%2.72B | 20.68%2.7B | 10.39%2.5B | -3.22%2.25B |
Long term receivable account | -50.00%4M | --4M | --4M | --8M | -33.33%8M | ---- | ---- | ---- | --12M | ---- |
Fixed assets | 7.49%100.59B | ---- | 11.26%97.92B | ---- | 9.48%93.58B | ---- | 1.21%88B | ---- | -4.98%85.48B | ---- |
Constru in process | 0.37%17.72B | ---- | 3.14%18.38B | ---- | -0.39%17.66B | ---- | 11.52%17.82B | ---- | 14.57%17.73B | ---- |
Intangible assets | 3.13%2.94B | 34.77%3.31B | 23.45%3.05B | 9.74%2.82B | 12.39%2.85B | -5.33%2.45B | -5.50%2.47B | -2.40%2.57B | -4.56%2.53B | 3.72%2.59B |
Goodwill | 0.00%9.03B | 0.02%9.03B | 0.02%9.03B | 0.02%9.03B | 0.00%9.03B | 0.00%9.03B | 0.00%9.03B | 0.00%9.03B | 0.02%9.03B | 0.00%9.03B |
Long deferred expense | -0.73%2.46B | 0.76%2.25B | 8.81%2.36B | 19.96%2.36B | 14.72%2.48B | 0.32%2.23B | -8.52%2.17B | -15.09%1.97B | -11.87%2.16B | 5.21%2.22B |
Deferred tax assets | -7.01%9.16B | -6.81%9.74B | -5.84%9.72B | -0.95%9.76B | -0.09%9.85B | 8.88%10.45B | 7.52%10.32B | 2.90%9.86B | 2.92%9.86B | 19.06%9.6B |
Usufruct assets | -5.17%109.83B | -14.79%102.13B | -10.64%108.22B | -6.78%114.66B | -8.11%115.82B | -1.63%119.85B | 0.69%121.11B | -0.25%123B | 1.10%126.04B | 0.53%121.84B |
Other non current assets | -5.30%1.52B | -29.32%1.48B | -23.86%1.55B | -22.24%1.58B | -20.59%1.6B | 1.11%2.09B | -1.50%2.03B | 3.05%2.03B | 1.10%2.02B | 0.44%2.06B |
Exceptional items of non current assets | ---- | ---- | -78.95%16M | -76.00%18M | -64.89%33M | ---- | 58.33%76M | --75M | --94M | --48M |
Total non current assets | 0.29%257.5B | -0.94%254.01B | -0.91%254.08B | -0.76%254.48B | -0.54%256.76B | 1.21%256.41B | 1.90%256.43B | 0.27%256.41B | -0.19%258.15B | -2.19%253.35B |
Total assets | -2.11%276.6B | -2.06%276.26B | -5.77%272.68B | -5.24%273.38B | -1.26%282.57B | -2.09%282.07B | -0.22%289.36B | 1.66%288.51B | -0.13%286.19B | 0.92%288.1B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -9.82%35.73B | 40.40%41.86B | -2.59%37.62B | -3.70%35.5B | -19.52%39.62B | -40.17%29.82B | -3.34%38.62B | 34.54%36.87B | 30.88%49.23B | 70.14%49.84B |
Notes payable and accounts payable | 54.76%24.93B | 21.72%21.09B | -12.39%14.46B | -12.10%15.2B | 40.66%16.11B | 7.96%17.33B | 25.62%16.5B | 27.73%17.29B | -5.12%11.45B | 3.18%16.05B |
-Notes payable | 410.45%12.8B | 1,004.73%5.37B | -89.08%177M | -76.35%465M | 233.51%2.51B | -84.30%486M | 67.63%1.62B | 6.85%1.97B | 0.53%752M | 44.49%3.1B |
-Accounts payable | -10.84%12.13B | -6.64%15.72B | -4.04%14.28B | -3.86%14.73B | 27.11%13.6B | 30.01%16.84B | 22.28%14.88B | 31.02%15.33B | -5.49%10.7B | -3.42%12.95B |
Contract liabilities | 43.87%10.68B | 41.57%8.49B | 28.06%9.34B | 52.57%7.04B | 125.52%7.42B | 95.50%5.99B | 122.04%7.29B | 61.34%4.61B | 0.12%3.29B | -3.83%3.07B |
Advance receipts | -25.00%15M | -77.27%5M | -76.92%6M | -47.92%25M | 25.00%20M | -77.55%22M | -35.00%26M | 108.70%48M | 23.08%16M | 34.25%98M |
Salaries payable | 29.59%3.18B | 14.34%2.34B | -30.87%1.88B | -43.81%1.43B | -4.80%2.46B | -10.82%2.04B | 37.42%2.72B | 56.37%2.55B | -6.38%2.58B | -31.28%2.29B |
Taxs payable | 12.28%2.09B | 24.60%2.16B | 11.16%1.9B | -3.02%1.77B | 37.15%1.86B | 42.32%1.73B | 50.84%1.71B | 35.82%1.82B | -24.53%1.35B | -16.18%1.22B |
Other payable (including interest and dividends) | -4.48%3.71B | 74.79%5.3B | -0.59%3.53B | 5.54%3.95B | -3.62%3.88B | -6.08%3.03B | 5.60%3.55B | -0.24%3.74B | 4.08%4.03B | -46.88%3.23B |
-Dividend payable | ---- | ---- | ---- | ---- | --29M | ---- | ---- | ---- | ---- | ---- |
-Other payable | --3.71B | ---- | ---- | ---- | ---- | ---- | 5.60%3.55B | ---- | 4.08%4.03B | ---- |
Non current liabilities due within one year | -3.81%33.28B | 2.05%34.86B | 11.38%36.17B | -9.04%26.54B | 0.63%34.59B | 19.78%34.16B | 18.12%32.48B | 13.59%29.17B | 41.65%34.38B | 51.27%28.52B |
Other current liabilities | 23.31%402M | -69.97%3.4B | 0.21%11.9B | -38.99%6.21B | 50.93%326M | 86.75%11.33B | -13.51%11.88B | -56.14%10.18B | 0.00%216M | -16.14%6.07B |
Exceptional items of current liabilities | ---- | --7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current liabilities | 7.26%114B | 13.32%119.5B | 1.77%116.81B | -8.12%97.65B | -0.25%106.28B | -4.45%105.45B | 10.23%114.78B | 6.88%106.28B | 24.05%106.54B | 29.75%110.37B |
Current liabilities | ||||||||||
Long term loan | -1.90%46.44B | -12.04%48.39B | -11.23%45.62B | -3.75%48.98B | 23.41%47.34B | 29.89%55.02B | 23.66%51.39B | 83.20%50.88B | 36.26%38.36B | 41.71%42.36B |
Bonds payable | -33.01%7.16B | -31.95%7.23B | -47.81%7.13B | -45.69%10.63B | -45.44%10.68B | -45.26%10.63B | -29.52%13.67B | 9.99%19.58B | -13.52%19.58B | -20.08%19.42B |
Long term account payable | -43.83%346M | ---- | -41.08%482M | ---- | -37.90%616M | ---- | -27.16%818M | ---- | -21.14%992M | ---- |
Long term salaries pay | 2.14%2.53B | 16.74%3.06B | 1.51%2.5B | -0.41%2.42B | -0.60%2.48B | 3.31%2.62B | -4.06%2.46B | -6.44%2.43B | -5.75%2.49B | 0.63%2.54B |
Specific account payable | 0.00%82M | ---- | 0.00%82M | ---- | 0.00%82M | ---- | 0.00%82M | ---- | 0.00%82M | ---- |
Estimate liabilities | -3.52%7.62B | -13.10%7.71B | -9.75%7.87B | -2.15%7.97B | -1.39%7.9B | 13.92%8.87B | 18.52%8.72B | 11.01%8.15B | 10.15%8.01B | 7.00%7.79B |
Deferred tax liabilities | 0.00%1M | --1M | --1M | ---- | --1M | ---- | ---- | --0 | ---- | ---- |
Long term deferred income | -14.81%46M | -15.52%49M | -13.79%50M | -13.11%53M | -16.92%54M | -19.44%58M | -27.50%58M | -29.89%61M | -28.57%65M | -29.41%72M |
Lease liabilities | -13.74%55.85B | -30.57%48.21B | -26.84%53.13B | -12.58%63.82B | -17.40%64.75B | -10.79%69.44B | -5.85%72.62B | -8.17%73B | -4.55%78.39B | -7.74%77.84B |
Other non current liabilities | 3.82%1.12B | -50.93%841M | -14.94%1.12B | -3.33%1.07B | -13.73%1.07B | 14.34%1.71B | -17.33%1.31B | -17.10%1.11B | -13.54%1.25B | -21.80%1.5B |
Total non current liabilities | -10.21%121.19B | -22.27%115.94B | -21.94%117.97B | -13.22%135.55B | -9.54%134.97B | -2.28%149.16B | 0.16%151.12B | 13.44%156.19B | 2.38%149.21B | 0.88%152.64B |
Total liabilities | -2.51%235.19B | -7.53%235.44B | -11.70%234.78B | -11.15%233.2B | -5.67%241.25B | -3.19%254.61B | 4.28%265.89B | 10.69%262.47B | 10.41%255.75B | 11.27%263.01B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%22.29B | 0.00%22.29B | 0.00%22.29B | 0.00%22.29B | 0.00%22.29B | 18.10%22.29B | 18.10%22.29B | 18.10%22.29B | 18.10%22.29B | 15.23%18.87B |
Other equity instruments | 24.98%25.07B | --20.5B | --20.35B | --20.2B | --20.06B | ---- | ---- | ---- | ---- | ---- |
-Equity of Perpetual debt | 24.98%25.07B | ---- | --20.35B | ---- | --20.06B | ---- | ---- | ---- | ---- | ---- |
Capital reserve funds | -0.24%53.02B | -0.88%53.02B | -0.88%53.02B | -0.88%53.02B | -0.72%53.15B | 27.55%53.49B | 27.55%53.49B | 27.55%53.49B | 27.66%53.53B | 24.77%41.93B |
Surplus reserve funds | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M | 0.00%782M |
Retained profit | -9.19%-57.32B | -12.61%-53.08B | -9.42%-55.56B | -10.58%-53.45B | -18.68%-52.5B | -33.69%-47.13B | -96.22%-50.78B | -224.34%-48.33B | -519.42%-44.23B | -1,022.83%-35.26B |
Less:Treasury stock | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other composite income | -7.01%-3.28B | -7.40%-3.25B | -8.10%-3.26B | -4.37%-3.15B | -3.76%-3.07B | -2.13%-3.03B | -0.30%-3.01B | 0.98%-3.02B | 3.90%-2.96B | -8.18%-2.96B |
Shareholders equity without minority interests | -0.44%40.53B | 52.50%40.26B | 65.21%37.63B | 57.45%39.7B | 38.40%40.71B | 12.97%26.4B | -30.38%22.78B | -42.23%25.21B | -42.74%29.42B | -47.94%23.37B |
Minority interests | 43.54%877M | -47.35%557M | -60.75%272M | -41.45%483M | -40.10%611M | -38.27%1.06B | -69.79%693M | -72.75%825M | -71.16%1.02B | -59.20%1.71B |
Total shareholder equity | 0.21%41.41B | 48.65%40.82B | 61.49%37.9B | 54.32%40.18B | 35.77%41.32B | 9.47%27.46B | -32.96%23.47B | -44.21%26.04B | -44.57%30.44B | -48.90%25.08B |
Total liabilityies and equity | -2.11%276.6B | -2.06%276.26B | -5.77%272.68B | -5.24%273.38B | -1.26%282.57B | -2.09%282.07B | -0.22%289.36B | 1.66%288.51B | -0.13%286.19B | 0.92%288.1B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.